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Background: More than 70% of patients with depression who see their doctors experience insomnia. Insomnia
treatment is a very important link for depression treatment. Furthermore, antidepression treatment is also important
for depression insomnia. In acupuncture, LU-7 (Lie Que) and KID-6 (Zhao Hai), which are two of the eight
confluence points in meridian theory, are used as main points. An embedded needle technique is used, alternately,
at two groups of points to consolidate the treatment effect. These two groups of points are BL-15 (Xin Shu) with
BL-23 (Shen Shu) and BL-19 (Dan Shu) with N-HN-54 (An Mian). The effectiveness of these optimized acupuncture
formulas is well proven in the practice by our senior acupuncturists in Guangdong Provincial Hospital of TCM. This
study has been designed to examine whether this set of optimized clinical formulas is able to increase the clinical
efficacy of depression insomnia treatment.
Methods/design: In this randomized controlled multicenter trial, all the eligible participants are diagnosed with
depression insomnia. All participants are randomly assigned to one of two groups in a ratio of 1:1 and receive
either conventional acupuncture treatment or optimized acupuncture treatment. Patients are evaluated using the
Pittsburgh Sleep Quality Index(PSQI)and the Hamilton rating scale(HAMD) for depression. The use of antidepression
and hypnotics drugs is also considered. Results are obtained at the start of treatment, 1 and 2 months after
treatment has begun, and at the end of treatment. The entire duration of the study will be approximately 36
months.
Discussion: A high quality of trial methodologies is utilized in the study, and the results may provide better
evidence for the effectiveness of acupuncture as a treatment for depression insomnia. The optimized acupuncture
formula has potential benefits in increasing the efficacy of treating depression insomnia.
Trial registration: The trial was registered in Chinese Clinical Trial Register (ChiCR-TRC-00000481) on 12 August
2009.Background
More than 20% of Chinese people with depression and
depressive neurosis experience from depressive symp-
toms [1]. Depression is a mental disorder with various
characteristics, including negative emotions, anxiety, agi-
tation, low self-esteem, dizziness, and suicidal tendencies
[2]. Excessive levels of disturbed sleep among patients
form one of the core symptoms known to be related
with depression [3,4]. The prevalence of patients with* Correspondence: fuwenbin@139.com
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reproduction in any medium, provided the ordepression and insomnia varies from 70.0% to 84.7%.
The Insomnia is likely to increase the risk of deterio-
ration and recurrence of depression, heart disease, social
functioning, and the risk of suicide. Moreover, insomnia
reduces the quality of life of patients with depression
[5,6]. Meanwhile, insomnia is one of the most-diagnosed
symptoms of depression and can be a risk factor for
intractable depression and a predictor of depression dis-
order recovery [7]. Therefore, for those patients with de-
pression insomnia, insomnia cannot simply be addressed
through the use pharmacological treatment or other
therapies for insomnia or depression. Treatments for
both are very important.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(TCM), has been applied for thousands of years [8]. The
rapid development of acupuncture both within and out-
side China over the last few decades has itself led to
great innovations in practice. Many studies, including
clinical reports and systematic reviews, have investigated
the benefits and success of acupuncture in relieving
symptoms for various acute and chronic diseases, while
a large history of clinical practice demonstrates that acu-
puncture appears to have an irreplaceable effect in trea-
ting depression and its symptoms, when compared with
modern medicine and its antidepressive treatment. How-
ever, methodological flaws in design undermine the
validity of these studies [9-11]. For example, two system-
atic reviews by Smith in the Cochrane Collaboration
show that the clinical evidence for acupuncture treat-
ment of depression is relatively limited before 2003 and
that the quality of the clinical trials has improved
between 2003 and 2008. The curative effects of acupunc-
ture for depression are impossible to confirm [12,13].
In view of these data,this randomized, controlled, mul-
ticenter study of depression insomnia patients aims to
determine the effectiveness of traditional acupuncture
techniques. The study will compare a conventional acu-
puncture treatment formula with an optimized acupunc-
ture treatment formula. The conventional acupuncture
treatment formula is based on a point selection estab-
lished on the basis of the particular TCM pattern of
depression. Depression in Chinese medicine is mainly
due to liver Qi stagnation, giving rise to symptoms
appearing to be mental disturbance. LI-4 (He Gu), LIV-3
(Tai Chong), EX-HN-3 (Yin Tang), and GV-20 (Bai Hui)
are the points of the conventional acupuncture treat-
ment formula. In optimized acupuncture formulas, the
two empirical points LU-7 (Lie Que) and KID-6 (Zhao
Hai) are added to the conventional acupuncture treat-
ment formula. The action of these two points is used to
improve the sleep quality of patients. Meanwhile, an
embedded needle technique has proved to be effective
for chronic disease or for those diseases demanding a
longer retention time. Therefore, the technique is used
to extend the effective treatment period in optimized
acupuncture formulas [14].
A measurement system for evaluating the progression
of illness, such as sleep quality and stress levels, will be




The objective of this trial is to evaluate the effectiveness
of treating depression insomnia by comparing the effects
of a conventional acupuncture treatment formula and an
optimized acupuncture treatment formula.Hypothesis
Acupuncture is capable of reducing levels of depression,
whether with a conventional treatment formula or an
optimized treatment formula. Furthermore, optimized
acupuncture is capable of reducing levels of depression
insomnia, to a greater degree than conventional acu-
puncture formula. Meanwhile, the results of the opti-
mized formula of acupuncture treatment for depression
insomnia are supposed to increase the clinical efficacy of
treating depression insomnia, improve the health-related
life quality of depression insomnia patients, and mode-
rate the consumption of drugs used in conventional
treatment, eventually leading to significant social and
economic benefits.
Design
This is a multicenter, randomized, controlled prospective
study. Participants receive optimized acupuncture (treat-
ment group), or conventional acupuncture (control
group) in a 1:1 allocation ratio (Figure 1).
Eligibility
Participants meeting the following criteria are included:
1. Patient meets the diagnostic criteria for depression in
the Chinese Classification of Mental Disorders, 3rd
edition [15].
2. Patient meets the chief diagnostic criteria for
insomnia (Diagnostic and Statistical Manual of
Mental Disorders, 4th edition [16].
3. The Hamilton rating scale for depression (HAMD)
count should be more than 20 points but less than or
equal to 35 points.
4. The total Pittsburgh Sleep Quality Index (PSQI)
count should be 7 points or over.
5. Patient is conscious without aphasia and mental
retardation and is able to understand the rating
scales.
6. Patients must be aged at least 16 years and not more
than 50 years, and may be male or female.
7. The course of disease is between 2 weeks and 2
years.
Participants meeting one or more of the following cri-
teria are excluded:
1. The depression is caused by organic mental
disorders, psychoactive drug substances, or non-
addictive substances.
2. Patients are aged less than 16 years or more than 50
years.
3. Patient is unable to understand the rating scales.
4. Pregnant women, patients with unstable heart
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Figure 1 Flowchart for the study.
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excluded.
5. Patients who cannot cooperate with their doctors are
excluded.
Withdrawal criteria and management
Withdrawal or dropout criteria:
1. At the participants’ own request or that of the legal
representative.
2. Participants who develop a serious disease, such as
heart disease or pneumonia and, in the investigator’s
opinion, it is not suitable to continue.
3. The participant’s compliance is poor, in the
investigators’ opinion,and it is not suitable that they
should keep taking part in the research.
4. The participants have an adverse reaction related
with acupuncture treatment.
Withdrawn subjects or dropouts should be managed
as follows. Details of the withdrawn patients should bedocumented in the ‘clinical trial performance forms’ in
the case report files (CRF) of the patients. Details of
patients who have withdrawn as a result of an adverse
event or reaction should be recorded in the CRF. If the
patients who have been determined as dropout or with-
drawn cases require further treatment, the investigators
should provide the treatments; however, their data will
be treated as missing data.Details of all withdrawn
patients will reported in the final results, to guarantee
maximum transparency.
Setting and participants
The study protocol was designed according to the Stan-
dards for Reporting Interventions in Clinical Trials
Acupuncture (SRICTA) [17].
Sample size calculation
The sample size calculation is based on the two-sided
chi-square test for difference with respect to the primary
endpoint. There are few reports in the literature of clinical
trialsof acupuncture treatment for depression insomnia.
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Guangdong Provincial Hospital of TCM, we decided to
adapt the reduction of the HAMD and PSQI scores as a
baseline for the sample size calculation for our trial. We
believe that the successful cure rate for depression insom-
nia is approximately 40% when adopting the conventional
acupuncture formula and should be increased to 70% or
more when using the optimized acupuncture formula. A
sample size of 58 patients per group is necessary (as calcu-
lated using PEMS version3.1 software,with the predicted
cure rates of 40% and 70%). The maximum dropout rate
within the intervention is expected to be about 15%.
Therefore, another 24 patients in total have to be
randomized to obtain the required number of patients.
The total number of patients needed to be randomized is
therefore 140.
Recruitment of patients
The patients are referred by the doctors and acupunctu-
rists from branch centers in Guangzhou, Huizhou, and
Zhaoqing city. 70 patients are from Guangdong Provin-
cial Hospital of TCM, 35 patients are from the second
people’s hospital of Zhaoqing city, and another 35
patients are from the People’s Hospital of Huizhou city.
Randomizations and procedures for setting
The study procedures, risks, benefits, and data manage-
ment are clarified in detail before the patients are asked to
give their informed consent. To achieve comparable
groups for known and unknown risk factors, a simple
randomization is performed. Both groups have equal
numbers of participants. The eligible participants are
divided into two groups; the control group (indicated as 1
in the CRF) and the treatment group (indicated as 2 in the
CRF). These groups will receive the acupuncture prescrip-
tion as basic treatment but the treatment group will also
be treated using the acupuncture points and techniques
especially for insomnia. After inputting the estimated sam-
ple size into PEMS version 3.1, a sequence number, seed
number, center number, and allocation result will be
obtained. The allocation to the treatment or control group
will then be performed using sealed consecutively num-
bered envelopes prepared by the trial team. Since this is a
multicenter trial, after the patient is registered, the practi-
tioners are informed, by telephone or other instant messen-
ging, of the patient’s assignation to one of the two study
formulas. This procedure ensures that the randomization is
not influenced by the investigators taking part in this study.
The practitioners participating in the study do not take part
in the randomization process.
Blind method
All eligible participants take part in a double-blind study.
The participants in both groups are blinded. Theevaluation of participants and analysis of results will be per-
formed by professionals blinded to the assignation of treat-
ment options. Those blinded professionals are required to
conduct the outcome assessments, collect medication
diaries, and check any missing data. Except for the practi-
tioners, all of those involved in the outcome assessment
are blinded to participant allocation.
Study treatment
The patients taking part in the study will each receive 24
acupuncture sessions (twice per week), either conven-
tional or optimized, as follows.
The treatment will be performed after sterilizing the
skin on the acupuncture point areas and with patients
lying face up. The temperature of the treatment room is
not lower than 25°C.
1. Conventional acupuncture treatment
All the patients in intervention group 1, the control
group, will receive the conventional acupuncture
formula at the following points: LI-4 (He Gu), LIV-3
(Tai Chong), EX-HN-3 (Yin Tang), and GV-20 (Bai
Hui). The needles, size 0.35 × 25 mm,are produced
by Suzhou Tianxie Acupuncture Instruments Co.,
Ltd. The needle are maintained in the acupuncture
points for 30 minutes. During the treatment, after a
De Qi sensation is produced, which is described as a
numb, distended and aching sensation, patients are
required to take six deep breaths and then have a
rest, followed by another six deep breaths every
minute until the needles are removed.
2. Optimized acupuncture treatment
The basic treatment formula is modified. On the
basis of the normal acupuncture, LU-7 (Lie Que) and
KID-6 (Zhao Hai) are added and needles remain in
the body after patient feels the De Qi sensation. The
embedded needles are then buried, for two groups of
points (1) Bl-15 (Xin Shu), Bl-23 (Shen Shu), and
Bl-19 (Dan Shu), N-HN-54 (An Mian); these two
groups of points are used alternately. The granular
type of embedded needle used has a needle tip of
about 2 or 3 mm and is manufactured by Suzhou
Medical Instrument Factory, China. The needle is
inserted perpendicularly underneath the skin and is
fixed with 3M medical proof fabric. Before the start
of the next treatment, the embedded needles are
removed.
To minimize treatment bias, all the acupuncturists
who participate in this trial are acupuncturists of a ge-
neral acupuncture department and each research center.
They all gained medical licenses in China and were well
trained according to the trial’s procedure under the guid-
ance of senior acupuncturists.
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processing
Common acupuncture adverse events or reaction
1. Needle fainting during acupuncture treatment
For patients who are on their first visit or have a
serious phobia about needles, a reassuring
explanation is necessary. The patient’s complexion
will be closely observed to check for any early
symptoms of needle fainting, such as discomfort,
dizziness, pale face, tiredness, sudden cold sweat,
cold limbs, weak breathing, pale and green
complexion, blue lips, low blood pressure, or
obnubilation. If these symptoms occur, the needles
should be removed as soon as possible. The patient is
then kepthorizontal with feet slightly raised, and
offered warm sugar water. If the symptoms are
serious, DU-26 (Shui Gou), DU-25 (Su Liao), PC-6
(Nei Guan), and ST-36 (Zu San Li) points are
selected as emergency points. If the symptoms
persist, other professional hospital emergency
measures may need to taken.
2. Convulsions
All acupuncturists must determine whether the
participants have a history of convulsion.If a patient
has a convulsion history during acupuncture
treatment, close observation is needed. The
practitioner will remove all the needles and take
some emergency measures. If the disease is not
immediately controlled or the convulsions persist,
the participants must be transferred to the
emergency center immediately.
3. Severe pains
Severe pains during and after treatment are usually
caused by improper needle manipulation or strong
stimulation. If the pain is of low intensity, a local
compress is used to stop the pain; if the pain is
heavier, moxibustion can be applied.
4. Needle sticking
If needle sticking occurs, the patients will be required
to relax. If the stickingis caused by twisting the
needle inone direction, the problem is solved by
rotating the needle in the opposite direction. If the
sticking is caused by the over-contraction of the
muscle, the needles are removed and the local area of
the acupuncture points is pressed, where the needle
is stuck, or another needle is placed in the local area,
to distract the patients’ attention. If the situation
occurs because of a change in the patients’ position,
it will be relieved when the patient resumes the
correct position.
5. Local infections
If a strict aseptic operation is ignored, local infection
occurs. Once the infection is diagnosed, propertreatment will be needed or drug therapy is
suggested.
6. Subcutaneous hematoma
During the acupuncture treatment, swelling and
bruising may occur when subcutaneous tiny vessels
are broken. Ice and local pressure are used to stop
the bleeding; at a later stage, a hot compress can be
applied and herbs used, to promote blood circulation
and remove the blood stasis.
Assessment of adverse events or reactions
If other adverse events or reactions occur during the
study process, the investigator should analyze the si-
tuation, in particular:
1. The temporal relationship between the acupuncture
and the adverse event, and whether there is
aconnection.
2. Whether the adverse event or reaction is relieved on
stopping the treatment.
3. Whether the adverse event or reaction occurs again,
when repeating the acupuncture treatment, on the
condition of ensuring the patient’s security and
consent.
4. Whether the adverse events or reactions can be
explained by the patient’s disease progress, a newly
occurring disease, or other therapies self-
administered by the patients.
Reportingadverse events orreactions
Any adverse events or reaction should be recorded in
the appropriate form in the CRF. The adverse events will
be reported to the principal investigator in Guangdong
Provincial hospital and the result of the assessment will
be recorded.
Data collection and outcome assessment
The data required for evaluating the effectiveness of the
treatment will be collected at baseline, at the start of the
treatment, 1 month after the treatment has begun, 2
months after the treatment has begun, and at the end of
the treatment. The data required for the blind method
cognitive evaluation will be collected after the second
acupuncture treatment and after the last treatment.
Primary outcomes
The PSQI, to ratesleep disorders, and HAMD, to rate
depression, were applied as primary outcome measure-
ments for effectiveness evaluation. The construction
validity and reliability of the PSQI to measure changes
in sleep qualityhave been proven in previous studies and
this scale has been validated for use in China. The PSQI
comprises 19 self-rated questions and 5 otherquestions,
all grouped into seven component scores (subjective
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ciency, sleep disturbance, hypnotic medication use, day-
time dysfunction), each weighted equally on a four-point
scale, from 0 to 3. The seven component scores are then
added to provide aPSQI score. A cutoff score of 5 has
been recommended, with scores >5 indicating subjective
insomnia [18]. Changes in levels of depression were
measured on the Hamilton hetero-evaluation scale.
There are three types of HAMD scale, with 17, 21, and
24 items. We used the 24-item HAMD scale. This scale
is of proven discriminant validity, reliability, and sensi-
tivity to change; moreover, it has been validated for use
in China. According to the scoring standard, a normal
score is less than 8; a score ≥8 and <20 indicates thatthe
patient may have depression; a score of ≥20 and ≤35
indicates thatthe patient definitely has depression; anda
scorehigher than 35 indicates that the patient has severe
depression. In general, the higher the score, the more
severe the depression [19].
Secondary outcomes
1. Combined medication record. Drugs such as
antidepressants and hypnotics medication consumed
during the trial (whether or not prescribed by the
patient’s doctor) will be recorded and measured on a
special scale. Antidepressants, analgesics, and
NSAIDs consumed (whether or not prescribed by
the patients doctor) atrandomization and at follow
up will be documented. These will be measured on a
four-point scale: 0=no medication; 1=less than the
usual dose; 2=daily, at the usual dose,3=greater than
the usual dose.
2. Blind method cognitive evaluation.
3. Baseline variables of patients such as age, sex,
education level, profession, income level, weight (kg)
and height (cm).
4. A record will be made of any side effects and
possible adverse reactions arising from the treatment.
Data storage and statistical analysis of the trial outcomes
The data compilation form containing the variables of
interest will be completed by the corresponding re-
searcher at each center. Data will be documented in the
paper CRF by researchers or evaluators and will be
double-checked by quality inspectors. The supervisor
will inspect the progress of the trial at regular intervals
in each branch center. All the detailed original data
(paper CRF) will be recorded timely, clearly, and com-
pletely. The case reports will be modified only by
researchers who are documenting the data. The correct
method of modification is tomark a line through the
original record and write the revised data next to the
original data,so that the change may be clearly visible.The modified data will be documented with data and the
initials of the investigator. All the materials will be kept
for 5 years after the completion of the study. At each
center, the information obtained will be recorded on an
electric database by EpiData software 3.1 at the same
time, for subsequent statistical analysis.
Predictive Analytics Software (PASW, version18.0) is
used for data analyses. Exploratory analysis will include
the minimum, maximum, median, mean, and standard
deviation. For measurement data, a normality test is
necessary. Furthermore, baseline categorical data, demo-
graphic characteristics, such as sex and age category,
and numerical data are analyzed with chi-squaretests
and one-way analyses of variance (ANOVA). Student’s
ttests are used tocompare different periods of measure-
ment data. Wilcoxon matched-pairs signed-rank tests
are used for ranked data. Independent Student’s ttests
and 95% confidence intervals are used to detect diffe-
rences between groups of the measurement data only if
the normality test and analysis of variancetestsprove
significant, otherwise rank-sum tests should be used,
which are also used to detect differences between groups
of ranked data. Linear mixed models (for continuous
outcome variables) and generalized estimating equations
(for categorical outcome variables) are used to examine
changes over time and the severity of PSQI and HAMD.
Both intention-to-treat and per-protocol analyses are
used. Data from participants who do not violate the
treatment protocols will be included in the per-protocol
analysis. Missing data are dealt with using the ‘last value
carried forward’ method.
Study organization
Statistical analysis will be carried out by the Design,
Measurement and Evaluation in Clinical Research
(DME) professionalsin Guangzhou University of TCM,
after approval of the protocol by the Ethics Committee
of Guangzhou Provincial Hospital of TCM, 2008GL-26,
2009-07-01. The trial is internationally registered at
Chinese Clinical Trial Register http://www.chictr.org/
(ChiCTR-TRC-00000481). A training working team will
be established, consisting of DME professionals of
Guangzhou University of TCM, staff of the scientific
research department and staff of the General Acupunc-
ture Department. The principle institution is Guangdong
Provincial Hospital of TCM and the cooperative institu-
tions are the Second People’s Hospital of Zhao Qing city
and the People’s Hospital of Hui Zhou. Data manage-
ment and statistical analysis will be carried out under
the guidance of DME professionals according to a pre-
specified statistical analysis plan. The clinical trial quality
control group will be established, and the investigator in
each branch center will be responsible for quality
control.
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Depression has various clinical manifestations and in-
somnia is one of the most frequently occurring symp-
toms. Clinically, we are not simply using regulating
spirit and regulating liver acupuncture formula. The for-
mula has been optimized. Lie Que (Lu-7) and Zhao Hai
(Kid-6) are two of the confluent points. The actions of
these two points can be best understood in relation to
the regulation of various meridians, three Jiao, and rela-
tive organs. These two empirical points are used as the
main points and embedded needles are buried to con-
solidate the curative effects of the acupuncture.
Trial status
The project was concluded in the 2011 and we expect to
publish the result at the end of 2013.
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